From April 3 to 6, 2025, the “40th Asia-Pacific Academy of Ophthalmology Congress (APAO 2025)” was grandly held in New Delhi, India. This global summit of ophthalmic wisdom attracted over 13,500 elite ophthalmologists from 89 countries and regions to explore cutting-edge topics in eye care.
At this largest and most diverse ophthalmic academic event in Asia in recent years, BigVision Medical forged a deep collaboration with SMR Ophthalmic, a renowned Indian eye care company, showcasing its AI-powered ophthalmic hardware and software products—including fully automated AI OCT devices—for the first time at the SMR booth. This marked the debut of “China’s intelligent innovation” on the international stage.
Based in Mumbai, SMR Ophthalmic is a leading eye care provider in India. The partnership signifies the integration of BigVision’s “AI+full automation” technology into India’s localized healthcare ecosystem, delivering tailored smart solutions for the South Asian market.
Under APAO’s theme of “Transcending Boundaries,” BigVision’s intelligent devices demonstrated breakthrough value in addressing healthcare disparities. A grassroots Indian doctor remarked, “AI technology simplifies complex examinations, enabling rapid screening of high-risk eye diseases even in remote areas.” This vision aligns with the “cross-regional collaboration” advocated by Professor Namrata Sharma, the local organizing committee chair and AIOS Scientific Committee president, underscoring the global significance of technology for equitable care.
During the exhibition, ophthalmic experts from Japan, Australia, Malaysia, and other nations gathered to experience the technology. A Mumbai-based ophthalmologist shared, “The BV1000 Series OCT’s automated design perfectly meets the needs of primary care in our country, with AI-assisted diagnosis bridging gaps in specialist availability.”
BigVision’s fully automated AI OCT simplifies operations with automated pupil alignment, focusing, and voice-guided patient instructions for self-administered within two minutes. This user-friendly design empowers healthcare workers at all levels, alleviating strain on overburdened systems. Integrated with advanced AI diagnostics, the device captures subtle retinal lesions in real time, aiding early detection of blinding conditions like diabetic retinopathy and age-related macular degeneration.
As traditional medicine meets artificial intelligence and Chinese innovation joins hands with Indian healthcare, a transformative ophthalmic revolution is bridging the Himalayas.
Leveraging the APAO platform, BigVision Medical will officially enter the Indian market in partnership with SMR Ophthalmic and local institutions. Its “AI Ophthalmic Matrix” is redefining India’s diagnostic landscape with frontier technology.
The collaboration between BigVision and SMR not only sets a new paradigm for global ophthalmic partnerships but also brings the ideal of “universal access to vision” to life.
No comments yet.